Horizon Therapeutics PLC (HZNP) News
Filter HZNP News Items
HZNP News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
HZNP News Highlights
- HZNP's 30 day story count now stands at 10.
- Over the past 23 days, the trend for HZNP's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about HZNP are BIO, EYE and TOP.
Latest HZNP News From Around the Web
Below are the latest news stories about HORIZON THERAPEUTICS PUBLIC LTD CO that investors may wish to consider to help them evaluate HZNP as an investment opportunity.
Rule 17(e) Announcement - Horizon Therapeutics plcDUBLIN, October 06, 2023-- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION |
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)DUBLIN, October 03, 2023--IRISH TAKEOVER PANEL |
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023DUBLIN, October 02, 2023--Horizon Therapeutics plc announces new UPLIZNA data in neuromyelitis optica spectrum disorder (NMOSD) to be presented at ECTRIMS 2023. |
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient OutcomesDUBLIN, September 29, 2023--Horizon Therapeutics announced new data on TEPEZZA (teprotumumab-trbw) and Thyroid Eye Disease (TED) at American Thyroid Association (ATA) 2023. |
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care IndustryDUBLIN, September 26, 2023--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named to U.S. News & World Report’s 2024 list of Best Companies to Work For in the Health Care Industry, ranking among the top companies recognized for employee wellbeing. |
The Hedge Fund That Made a Killing Betting Against Lina KhanThe efforts by Federal Trade Commission Chair Lina Khan to protect Main Street are inadvertently enriching some on Wall Street, generating outsize profits for Pentwater Capital Management and other large hedge funds that bet on merger deals. In both cases, the FTC’s intervention spooked investors and sent shares of the target companies swinging. |
FTC chair targets deals that have fallen in agency's 'blind spots'FTC chair Lina Khan has her sights focused on challenging mergers & acquisitions in the healthcare and tech sectors, specifically those valued under $100 million. Khan argues that these mergers can snowball into larger monopolies when left unchecked. Senior Reporter for Yahoo Finance Anjalee Khemlani joins to breakdown Lina Khan's recent statement at the Oliver Wyman Health Innovation Summit in Chicago. |
Healthcare: FTC Chair Lina Khan to crack down on 'below radar' dealsFTC Chair Lina Khan wants to help create more competition in the market and avoid monopolies. |
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 ListDUBLIN, September 19, 2023--Horizon Therapeutics plc (Nasdaq: HZNP) announced it has been named No. 1 on the Fortune Best Workplaces in Biopharma 2023 list in the large company category. This is the seventh consecutive year Horizon has been named to the list and the company’s fourth time ranking No. 1. |
The 3 Most Undervalued Biotech Stocks to Buy in September 2023While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners. |